A phase II trial of chimeric monoclonal antibody G250 for advanced renal cell carcinoma patients.
Bleumer I, Knuth A, Oosterwijk E, Hofmann R, Varga Z, Lamers C, Kruit W, Melchior S, Mala C, Ullrich S, De Mulder P, Mulders PF, Beck J.
Bleumer I, et al.
Br J Cancer. 2004 Mar 8;90(5):985-90. doi: 10.1038/sj.bjc.6601617.
Br J Cancer. 2004.
PMID: 14997194
Free PMC article.
Clinical Trial.